TrialBMJ (Clinical research ed.)2024

Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial.

Guo-Ying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.